20Apr 2025
Blocking LSD1 Halts Oral Cancer Progression: New Study Uncovers Epigenetic Target in OSCC Development

Blocking LSD1 Halts Oral Cancer Progression: New Study Uncovers Epigenetic Target in OSCC Development

A new study identifies lysine-specific demethylase 1 (LSD1) as a key driver in the progression of preneoplastic lesions to oral squamous cell carcinoma (OSCC). Inhibiting LSD1 reverses preneoplasia, disrupts immunosuppression, and suppresses STAT3 signaling, highlighting LSD1 as a promising therapeutic target.

  • #oncology

Like

Save

Share